Logo image
Se connecter
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
Article de revue   Avec comité de lecture

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

Marius Ilié, Julien Mazières, Emmanuel Chamorey, Simon Heeke, Jonathan Benzaquen, Brice Thamphya, Jacques Boutros, Angélica Tiotiu, Julien Fayada, Jacques Cadranel, …
Journal of thoracic oncology, Vol.16(9), pp.1547-1558
09/2021

Résumé

Cancer Human health and pathology Life Sciences Pulmonology and respiratory tract

Détails

Logo image